alexa Exploiting the Inherent Metastasis of Leukemia to Impro
ISSN: 2168-9296

Cell & Developmental Biology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Exploiting the Inherent Metastasis of Leukemia to Improve Chemotherapeutic Approaches

Matthew Trendowski*
Department of Biology; Syracuse University, 107 College Place; Syracuse, NY 13244, USA
*Corresponding Author : Matthew Trendowski
Department of Biology; Syracuse University
107 College Place; Syracuse, NY 13244, USA
Tel: 315-807-8991
E-mail: [email protected]
Received March 14, 2014; Accepted May 29, 2014; Published June 02, 2014
Citati on: Trendowski M (2014) Exploiting the Inherent Metastasis of Leukemia to Improve Chemotherapeutic Approaches. Cell Dev Biol 3:137. doi:10.4172/2168-9296.1000137
Copyright: © 2014 Trendowski M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
 

Abstract

Nearly all cancers are linked by the inexorable phenotype of metastasis as malignant growths have the capability to spread from their place of origin to distant sites throughout the body. While different cancers may have various propensities to migrate towards specific locations, they are all linked by this unifying principal. Unlike most neoplasms, leukemia has inherent cell motility as leukocytes are required to move throughout the vascular system, suggesting that no mutations are required for anchorage independent growth. As such, it seems likely that leukemias are inherently metastatic, endowed with cancer’s deadliest phenotype simply due to cell of origin. This article presents the biology of metastasis development and how leukemia cells are inherently provided this devastating phenotype. It is then elucidated how clinicians may be able to exploit the motility of leukemia and metastatic emboli of other cancer types through an approach known as Sonodynamic Therapy (SDT), a treatment modality that combines chemotherapeutic agents with ultrasonic irradiation to preferentially damage malignant cells. As experimental evidence has indicated, SDT is a promising therapeutic approach in need of clinical testing for further validation.

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords